Filing Details

Accession Number:
0001209191-17-067133
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-22 18:08:25
Reporting Period:
2017-12-20
Accepted Time:
2017-12-22 18:08:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1590750 Miragen Therapeutics Inc. MGEN Services-Medical Laboratories (8071) 471187261
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611048 E. Thomas Hughes C/o Miragen Therapeutics, Inc.
6200 Lookout Road
Boulder CO 80301
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-12-20 12,000 $8.00 2,827 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Includes 765 shares previously reported as holdings of the Reporting Person granted pursuant to a restricted stock award under the Issuer's 2016 Equity Incentive Plan.